Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionchromatin binding

FOXA2 ZC3H4 CREBBP AKAP8

1.83e-03739154GO:0003682
GeneOntologyMolecularFunctionSMAD binding

FOXA2 CREBBP

1.86e-0386152GO:0046332
GeneOntologyMolecularFunctiontranscription factor binding

FOXA2 CXXC5 CREBBP AKAP8

1.96e-03753154GO:0008134
GeneOntologyMolecularFunctionprotein domain specific binding

FOXA2 CBLB CREBBP HNRNPM

3.39e-03875154GO:0019904
GeneOntologyMolecularFunctionzinc ion binding

CXXC5 CBLB CREBBP AKAP8

3.62e-03891154GO:0008270
GeneOntologyCellularComponentpronucleus

HNRNPL AKAP8

1.80e-0428152GO:0045120
GeneOntologyCellularComponentchromatin

FOXA2 CREBBP IRF4 HNRNPL AKAP8 KANSL1

3.57e-041480156GO:0000785
GeneOntologyCellularComponentcondensed chromosome

CREBBP AKAP8 KANSL1

1.25e-03307153GO:0000793
GeneOntologyCellularComponenthistone acetyltransferase complex

CREBBP KANSL1

2.02e-0394152GO:0000123
GeneOntologyCellularComponentprotein acetyltransferase complex

CREBBP KANSL1

2.47e-03104152GO:0031248
GeneOntologyCellularComponentacetyltransferase complex

CREBBP KANSL1

2.71e-03109152GO:1902493
GeneOntologyCellularComponentnuclear matrix

HNRNPM AKAP8

4.42e-03140152GO:0016363
GeneOntologyCellularComponentnuclear periphery

HNRNPM AKAP8

6.51e-03171152GO:0034399
GeneOntologyCellularComponentkinetochore

CREBBP KANSL1

7.27e-03181152GO:0000776
GeneOntologyCellularComponentcondensed chromosome, centromeric region

CREBBP KANSL1

8.23e-03193152GO:0000779
GeneOntologyCellularComponentspliceosomal complex

HNRNPH3 HNRNPM

1.01e-02215152GO:0005681
DomainRRM_1

HNRNPH3 HNRNPL HNRNPM

5.61e-04208153PF00076
DomainRRM

HNRNPH3 HNRNPL HNRNPM

6.35e-04217153SM00360
DomainRRM_dom

HNRNPH3 HNRNPL HNRNPM

7.24e-04227153IPR000504
DomainRRM

HNRNPH3 HNRNPL HNRNPM

7.52e-04230153PS50102
Domain-

HNRNPH3 HNRNPL HNRNPM

8.92e-042441533.30.70.330
DomainNucleotide-bd_a/b_plait

HNRNPH3 HNRNPL HNRNPM

1.05e-03258153IPR012677
Domain-

FOXA2 IRF4

1.29e-022181521.10.10.10
DomainWHTH_DNA-bd_dom

FOXA2 IRF4

1.57e-02242152IPR011991
PathwayBIOCARTA_PCAF_PATHWAY

CREBBP IRF4

5.15e-0513122M22007
PathwayREACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT

FOXA2 CREBBP

5.61e-0442122M17541
PathwayPID_HNF3A_PATHWAY

FOXA2 CREBBP

6.16e-0444122M285
PathwayPID_NFAT_TFPATHWAY

CBLB IRF4

6.44e-0445122M60
PathwayPID_HEDGEHOG_GLI_PATHWAY

FOXA2 CREBBP

7.33e-0448122M219
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

DSC3 HNRNPH3 SIPA1L3 HNRNPL HNRNPM AKAP8

1.07e-0927415634244482
Pubmed

DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.

HNRNPH3 HNRNPL HNRNPM AKAP8

5.35e-088915422446626
Pubmed

Spatiotemporal regulation of hnRNP M and 2H9 gene expression during mouse embryonic development.

HNRNPH3 HNRNPM

1.74e-07215211004512
Pubmed

Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.

ZC3H4 HNRNPH3 HNRNPL HNRNPM

2.95e-0713615426979993
Pubmed

Association between hepatocyte nuclear factor 6 (HNF-6) and FoxA2 DNA binding domains stimulates FoxA2 transcriptional activity but inhibits HNF-6 DNA binding.

FOXA2 CREBBP

1.04e-06415212509444
Pubmed

Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.

HNRNPL HNRNPM

1.04e-06415221398516
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

ZC3H4 HNRNPH3 SIPA1L3 HNRNPL HNRNPM AKAP8

1.39e-0692215627609421
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8 KANSL1

1.88e-0697115633306668
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

2.58e-0655115534728620
Pubmed

Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.

HNRNPH3 HNRNPL HNRNPM AKAP8

3.04e-0624415429884807
Pubmed

SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.

HNRNPH3 HNRNPL HNRNPM AKAP8

3.79e-0625815437794589
Pubmed

Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.

HNRNPH3 HNRNPL HNRNPM AKAP8

3.90e-0626015436199071
Pubmed

Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses.

FOXA2 CREBBP

6.24e-06915235675826
Pubmed

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

HNRNPH3 HNRNPL HNRNPM

6.97e-068815326318153
Pubmed

Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.

HNRNPL HNRNPM AKAP8

7.45e-069015333087562
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

DSC3 HNRNPH3 SIPA1L3 HNRNPL HNRNPM AKAP8

8.33e-06125715636526897
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

9.04e-0671315529802200
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

HNRNPH3 SIPA1L3 HNRNPL HNRNPM AKAP8

9.10e-0671415528302793
Pubmed

Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.

HNRNPH3 HNRNPL

9.53e-061115221900255
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

CXXC5 HNRNPH3 HNRNPL HNRNPM AKAP8 KANSL1

9.83e-06129415630804502
Pubmed

hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.

HNRNPH3 HNRNPL HNRNPM AKAP8

1.21e-0534615425324306
Pubmed

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.

DSC3 HNRNPL HNRNPM

1.25e-0510715332989256
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

DSC3 CREBBP HNRNPH3 HNRNPL HNRNPM KANSL1

1.27e-05135315629467282
Pubmed

Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.

ZC3H4 CREBBP HNRNPL HNRNPM

1.42e-0536115430344098
Pubmed

Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.

HNRNPH3 HNRNPL HNRNPM

1.52e-0511415331553912
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

1.64e-0580715522681889
Pubmed

Human transcription factor protein interaction networks.

CREBBP IRF4 HNRNPH3 HNRNPL AKAP8 KANSL1

1.73e-05142915635140242
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

CBLB ZC3H4 HNRNPL HNRNPM AKAP8

2.08e-0584715535850772
Pubmed

Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules.

FOXA2 CREBBP

2.08e-051615222780989
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

FOXA2 CREBBP HNRNPL AKAP8 KANSL1

2.20e-0585715525609649
Pubmed

KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.

HNRNPL HNRNPM AKAP8

2.25e-0513015335545047
Pubmed

Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.

HNRNPH3 HNRNPL HNRNPM

2.30e-0513115334551306
Pubmed

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.

HNRNPH3 HNRNPL HNRNPM AKAP8

2.60e-0542115434650049
Pubmed

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.

ZC3H4 IRF4 HNRNPL

3.31e-0514815332538781
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

FOXA2 CREBBP HNRNPM AKAP8

3.58e-0545715432344865
Pubmed

TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.

HNRNPL HNRNPM

3.99e-052215217803295
Pubmed

RNA-Binding Protein IGF2BP2/IMP2 is a Critical Maternal Activator in Early Zygotic Genome Activation.

HNRNPL HNRNPM

3.99e-052215231406667
Pubmed

LINKIN, a new transmembrane protein necessary for cell adhesion.

HNRNPH3 HNRNPL HNRNPM AKAP8

4.33e-0548015425437307
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

4.36e-0598915536424410
Pubmed

A human MAP kinase interactome.

CBLB CREBBP HNRNPM KANSL1

4.55e-0548615420936779
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

HNRNPH3 HNRNPL HNRNPM AKAP8

4.85e-0549415426831064
Pubmed

Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin.

HNRNPH3 HNRNPL HNRNPM

5.00e-0517015316159877
Pubmed

Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis.

HNRNPL HNRNPM AKAP8

5.18e-0517215326336360
Pubmed

DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.

HNRNPL HNRNPM AKAP8

5.45e-0517515325756610
Pubmed

HIV/AIDS. Persistence by proliferation?

CREBBP HNRNPM

5.61e-052615225013050
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

6.68e-05108215538697112
Pubmed

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.

HNRNPL HNRNPM

8.55e-053215236252997
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

APBB1IP HNRNPM AKAP8 KANSL1

9.15e-0558215420467437
Pubmed

Functional proteomics mapping of a human signaling pathway.

CXXC5 CBLB CREBBP KANSL1

9.71e-0559115415231748
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

HNRNPH3 HNRNPL HNRNPM AKAP8

1.06e-0460515428977666
Pubmed

ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.

HNRNPH3 SIPA1L3 HNRNPL HNRNPM

1.20e-0462415433729478
Pubmed

The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.

HNRNPL AKAP8

1.34e-044015234004371
Pubmed

Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing.

HNRNPL HNRNPM

1.34e-044015223825951
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

ZC3H4 HNRNPL HNRNPM AKAP8

1.43e-0465315433742100
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

ZC3H4 HNRNPL HNRNPM AKAP8

1.44e-0465515435819319
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

HNRNPH3 SIPA1L3 HNRNPL HNRNPM

1.49e-0466015432780723
Pubmed

The ORC ubiquitin ligase OBI1 promotes DNA replication origin firing.

HNRNPM AKAP8

1.63e-044415231160578
Pubmed

A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.

HNRNPH3 HNRNPL HNRNPM

1.64e-0425415328431233
Pubmed

A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.

HNRNPH3 HNRNPM

1.70e-044515225496916
Pubmed

Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes.

HNRNPH3 HNRNPL

1.70e-04451521286667
Pubmed

Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.

HNRNPL HNRNPM AKAP8

1.74e-0425915331162944
Pubmed

The protein interaction landscape of the human CMGC kinase group.

CREBBP SIPA1L3 HNRNPM AKAP8

1.81e-0469515423602568
Pubmed

PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.

HNRNPL HNRNPM

1.86e-044715229934401
Pubmed

Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.

ZC3H4 HNRNPH3 HNRNPL HNRNPM

2.20e-0473115429298432
Pubmed

The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.

HNRNPM AKAP8

2.54e-045515231640799
Pubmed

EIF3H Orchestrates Hippo Pathway-Mediated Oncogenesis via Catalytic Control of YAP Stability.

HNRNPL HNRNPM

2.54e-045515232269044
Pubmed

Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.

SIPA1L3 HNRNPL HNRNPM

2.55e-0429515326209609
Pubmed

Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

HNRNPH3 HNRNPL

2.83e-045815230009671
Pubmed

STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.

SIPA1L3 HNRNPL HNRNPM

3.12e-0431615331665637
Pubmed

TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.

HNRNPL HNRNPM AKAP8

3.15e-0431715330997501
Pubmed

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

CBLB HNRNPH3 SIPA1L3

3.45e-0432715315592455
Pubmed

Interactome analysis of Bag-1 isoforms reveals novel interaction partners in endoplasmic reticulum-associated degradation.

HNRNPH3 HNRNPL HNRNPM

3.45e-0432715334428256
Pubmed

The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.

HNRNPH3 HNRNPL HNRNPM

3.54e-0433015332529326
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

HNRNPL HNRNPM AKAP8

3.86e-0434015324332808
Pubmed

Interaction between the scaffold proteins CBP by IQGAP1 provides an interface between gene expression and cytoskeletal activity.

CREBBP HNRNPL

4.01e-046915232238831
Pubmed

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.

HNRNPH3 HNRNPL HNRNPM

4.31e-0435315327545878
InteractionGLDC interactions

DSC3 HNRNPH3 SIPA1L3 HNRNPL HNRNPM AKAP8

6.91e-08321156int:GLDC
InteractionKDM6A interactions

CREBBP IRF4 HNRNPL KANSL1

5.13e-06162154int:KDM6A
InteractionFUS interactions

ZC3H4 CREBBP HNRNPH3 HNRNPL HNRNPM AKAP8

1.03e-05757156int:FUS
InteractionRBM45 interactions

ZC3H4 HNRNPH3 HNRNPL HNRNPM

1.35e-05207154int:RBM45
InteractionMIR138-1 interactions

HNRNPH3 HNRNPL HNRNPM

1.62e-0568153int:MIR138-1
InteractionMIR9-3 interactions

HNRNPH3 HNRNPL HNRNPM

1.77e-0570153int:MIR9-3
InteractionMIR140 interactions

HNRNPH3 HNRNPL HNRNPM

1.85e-0571153int:MIR140
InteractionMIR122 interactions

HNRNPH3 HNRNPL HNRNPM

1.85e-0571153int:MIR122
InteractionMIR29B2 interactions

HNRNPH3 HNRNPL HNRNPM

1.85e-0571153int:MIR29B2
InteractionTTLL11 interactions

HNRNPL HNRNPM

1.86e-059152int:TTLL11
InteractionSNRPA interactions

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

1.89e-05482155int:SNRPA
InteractionMIR18A interactions

HNRNPH3 HNRNPL HNRNPM

2.01e-0573153int:MIR18A
InteractionMIR29B1 interactions

HNRNPH3 HNRNPL HNRNPM

2.01e-0573153int:MIR29B1
InteractionMIR20A interactions

HNRNPH3 HNRNPL HNRNPM

2.09e-0574153int:MIR20A
InteractionMIR15A interactions

HNRNPH3 HNRNPL HNRNPM

2.18e-0575153int:MIR15A
InteractionMIR7-3 interactions

HNRNPH3 HNRNPL HNRNPM

2.27e-0576153int:MIR7-3
InteractionMIR16-1 interactions

HNRNPH3 HNRNPL HNRNPM

2.27e-0576153int:MIR16-1
InteractionMIR199A2 interactions

HNRNPH3 HNRNPL HNRNPM

2.27e-0576153int:MIR199A2
InteractionMIR429 interactions

HNRNPH3 HNRNPL HNRNPM

2.27e-0576153int:MIR429
InteractionONECUT1 interactions

FOXA2 CREBBP

2.32e-0510152int:ONECUT1
InteractionMIR9-2 interactions

HNRNPH3 HNRNPL HNRNPM

2.36e-0577153int:MIR9-2
InteractionMIR200A interactions

HNRNPH3 HNRNPL HNRNPM

2.36e-0577153int:MIR200A
InteractionMIR92A1 interactions

HNRNPH3 HNRNPL HNRNPM

2.45e-0578153int:MIR92A1
InteractionMIR98 interactions

HNRNPH3 HNRNPL HNRNPM

2.45e-0578153int:MIR98
InteractionMIR451A interactions

HNRNPH3 HNRNPL HNRNPM

2.45e-0578153int:MIR451A
InteractionKAT6A interactions

CREBBP HNRNPH3 HNRNPL HNRNPM KANSL1

2.48e-05510155int:KAT6A
InteractionMIR222 interactions

HNRNPH3 HNRNPL HNRNPM

2.55e-0579153int:MIR222
InteractionMIR206 interactions

HNRNPH3 HNRNPL HNRNPM

2.55e-0579153int:MIR206
InteractionMIR1-2 interactions

HNRNPH3 HNRNPL HNRNPM

2.55e-0579153int:MIR1-2
InteractionMIR34C interactions

HNRNPH3 HNRNPL HNRNPM

2.55e-0579153int:MIR34C
InteractionMIR143 interactions

HNRNPH3 HNRNPL HNRNPM

2.65e-0580153int:MIR143
InteractionMIR145 interactions

HNRNPH3 HNRNPL HNRNPM

2.75e-0581153int:MIR145
InteractionMIR10B interactions

HNRNPH3 HNRNPL HNRNPM

2.85e-0582153int:MIR10B
InteractionCPSF6 interactions

ZC3H4 CREBBP HNRNPL HNRNPM AKAP8

2.87e-05526155int:CPSF6
InteractionMIR106A interactions

HNRNPH3 HNRNPL HNRNPM

2.96e-0583153int:MIR106A
InteractionMIR31 interactions

HNRNPH3 HNRNPL HNRNPM

3.07e-0584153int:MIR31
InteractionMIR7-2 interactions

HNRNPH3 HNRNPL HNRNPM

3.07e-0584153int:MIR7-2
InteractionMIR199A1 interactions

HNRNPH3 HNRNPL HNRNPM

3.07e-0584153int:MIR199A1
InteractionMIR200B interactions

HNRNPH3 HNRNPL HNRNPM

3.07e-0584153int:MIR200B
InteractionMIR107 interactions

HNRNPH3 HNRNPL HNRNPM

3.18e-0585153int:MIR107
InteractionMIR17 interactions

HNRNPH3 HNRNPL HNRNPM

3.18e-0585153int:MIR17
InteractionMIR18B interactions

HNRNPH3 HNRNPL HNRNPM

3.18e-0585153int:MIR18B
InteractionMIR93 interactions

HNRNPH3 HNRNPL HNRNPM

3.18e-0585153int:MIR93
InteractionMIR9-1 interactions

HNRNPH3 HNRNPL HNRNPM

3.18e-0585153int:MIR9-1
InteractionMIR16-2 interactions

HNRNPH3 HNRNPL HNRNPM

3.18e-0585153int:MIR16-2
InteractionMIR20B interactions

HNRNPH3 HNRNPL HNRNPM

3.29e-0586153int:MIR20B
InteractionMIR29A interactions

HNRNPH3 HNRNPL HNRNPM

3.41e-0587153int:MIR29A
InteractionMIR141 interactions

HNRNPH3 HNRNPL HNRNPM

3.52e-0588153int:MIR141
InteractionMIR138-2 interactions

HNRNPH3 HNRNPL HNRNPM

3.52e-0588153int:MIR138-2
InteractionMIR29C interactions

HNRNPH3 HNRNPL HNRNPM

3.65e-0589153int:MIR29C
InteractionRBM14 interactions

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

3.65e-05553155int:RBM14
InteractionCEBPB interactions

ZC3H4 CREBBP IRF4 HNRNPH3 HNRNPL HNRNPM AKAP8

3.67e-051443157int:CEBPB
InteractionMIR221 interactions

HNRNPH3 HNRNPL HNRNPM

3.77e-0590153int:MIR221
InteractionMIR92A2 interactions

HNRNPH3 HNRNPL HNRNPM

3.77e-0590153int:MIR92A2
InteractionMIR1-1 interactions

HNRNPH3 HNRNPL HNRNPM

3.77e-0590153int:MIR1-1
InteractionTNIP2 interactions

ZC3H4 HNRNPH3 SIPA1L3 HNRNPL HNRNPM AKAP8

3.79e-05952156int:TNIP2
InteractionCCND3 interactions

CREBBP HNRNPL AKAP8

3.90e-0591153int:CCND3
InteractionMIR200C interactions

HNRNPH3 HNRNPL HNRNPM

3.90e-0591153int:MIR200C
InteractionMIR155 interactions

HNRNPH3 HNRNPL HNRNPM

4.03e-0592153int:MIR155
InteractionMIR128-1 interactions

HNRNPH3 HNRNPL HNRNPM

4.03e-0592153int:MIR128-1
InteractionDDX5 interactions

CREBBP HNRNPH3 HNRNPL HNRNPM AKAP8

4.15e-05568155int:DDX5
InteractionMIR214 interactions

HNRNPH3 HNRNPL HNRNPM

4.16e-0593153int:MIR214
InteractionMIR205 interactions

HNRNPH3 HNRNPL HNRNPM

4.16e-0593153int:MIR205
InteractionZNF608 interactions

IRF4 HNRNPL KANSL1

4.16e-0593153int:ZNF608
InteractionMIR19B2 interactions

HNRNPH3 HNRNPL HNRNPM

4.29e-0594153int:MIR19B2
InteractionMIRLET7F1 interactions

HNRNPH3 HNRNPL HNRNPM

4.29e-0594153int:MIRLET7F1
InteractionMIRLET7A2 interactions

HNRNPH3 HNRNPL HNRNPM

4.57e-0596153int:MIRLET7A2
InteractionTOPORS interactions

CREBBP HNRNPL HNRNPM

4.57e-0596153int:TOPORS
InteractionMIRLET7C interactions

HNRNPH3 HNRNPL HNRNPM

4.72e-0597153int:MIRLET7C
InteractionMIR21 interactions

HNRNPH3 HNRNPL HNRNPM

4.72e-0597153int:MIR21
InteractionMIRLET7F2 interactions

HNRNPH3 HNRNPL HNRNPM

4.72e-0597153int:MIRLET7F2
InteractionMIR363 interactions

HNRNPH3 HNRNPL HNRNPM

4.72e-0597153int:MIR363
InteractionMIR106B interactions

HNRNPH3 HNRNPL HNRNPM

4.86e-0598153int:MIR106B
InteractionMIR128-2 interactions

HNRNPH3 HNRNPL HNRNPM

5.01e-0599153int:MIR128-2
InteractionMIR19A interactions

HNRNPH3 HNRNPL HNRNPM

5.17e-05100153int:MIR19A
InteractionMIRLET7B interactions

HNRNPH3 HNRNPL HNRNPM

5.32e-05101153int:MIRLET7B
InteractionMIRLET7D interactions

HNRNPH3 HNRNPL HNRNPM

5.32e-05101153int:MIRLET7D
InteractionMIR25 interactions

HNRNPH3 HNRNPL HNRNPM

5.32e-05101153int:MIR25
InteractionPLEKHH1 interactions

APBB1IP HNRNPL

5.40e-0515152int:PLEKHH1
InteractionMIRLET7A3 interactions

HNRNPH3 HNRNPL HNRNPM

5.48e-05102153int:MIRLET7A3
InteractionMIR15B interactions

HNRNPH3 HNRNPL HNRNPM

5.64e-05103153int:MIR15B
InteractionMIR7-1 interactions

HNRNPH3 HNRNPL HNRNPM

5.64e-05103153int:MIR7-1
InteractionPTK6 interactions

CBLB HNRNPL HNRNPM

5.81e-05104153int:PTK6
InteractionMIR19B1 interactions

HNRNPH3 HNRNPL HNRNPM

5.81e-05104153int:MIR19B1
InteractionMIR34A interactions

HNRNPH3 HNRNPL HNRNPM

5.81e-05104153int:MIR34A
InteractionMIRLET7E interactions

HNRNPH3 HNRNPL HNRNPM

6.15e-05106153int:MIRLET7E
InteractionADSS1 interactions

HNRNPL HNRNPM

6.17e-0516152int:ADSS1
InteractionMYD88 interactions

CBLB IRF4 HNRNPL

6.32e-05107153int:MYD88
InteractionMIRLET7A1 interactions

HNRNPH3 HNRNPL HNRNPM

6.50e-05108153int:MIRLET7A1
InteractionMIR34B interactions

HNRNPH3 HNRNPL HNRNPM

6.86e-05110153int:MIR34B
InteractionMIRLET7I interactions

HNRNPH3 HNRNPL HNRNPM

7.63e-05114153int:MIRLET7I
InteractionMIRLET7G interactions

HNRNPH3 HNRNPL HNRNPM

8.25e-05117153int:MIRLET7G
InteractionKLF8 interactions

CREBBP HNRNPH3 HNRNPL AKAP8

8.26e-05329154int:KLF8
InteractionSPIB interactions

CREBBP IRF4

9.75e-0520152int:SPIB
InteractionSSRP1 interactions

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8

1.01e-04685155int:SSRP1
InteractionTOP1 interactions

ZC3H4 IRF4 HNRNPL HNRNPM AKAP8

1.09e-04696155int:TOP1
InteractionCXXC5 interactions

CXXC5 HNRNPL

1.18e-0422152int:CXXC5
InteractionFZR1 interactions

ZC3H4 HNRNPH3 HNRNPL HNRNPM AKAP8 KANSL1

1.21e-041172156int:FZR1
InteractionPPP1CC interactions

ZC3H4 CREBBP HNRNPH3 HNRNPL HNRNPM

1.44e-04738155int:PPP1CC
InteractionHOXB13 interactions

FOXA2 IRF4

1.54e-0425152int:HOXB13
CytobandEnsembl 112 genes in cytogenetic band chr19q13

ZC3H4 SIPA1L3 HNRNPL

6.29e-031192153chr19q13
CytobandEnsembl 112 genes in cytogenetic band chr19p13

HNRNPM AKAP8

2.72e-02797152chr19p13
GeneFamilyRNA binding motif containing

HNRNPH3 HNRNPL HNRNPM

4.23e-04213133725
CoexpressionMARTENS_BOUND_BY_PML_RARA_FUSION

CXXC5 ZC3H4 APBB1IP HNRNPM

1.06e-04456154M2094
CoexpressionGSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP

CBLB IRF4 HNRNPL

1.28e-04176153M6882
CoexpressionGSE39556_CD8A_DC_VS_NK_CELL_DN

CBLB IRF4 SIPA1L3

1.81e-04198153M9407
CoexpressionGSE14308_TH1_VS_NATURAL_TREG_DN

CXXC5 SIPA1L3 KANSL1

1.83e-04199153M3381
CoexpressionGSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP

CBLB CREBBP APBB1IP

1.83e-04199153M7596
CoexpressionGSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN

CBLB CREBBP APBB1IP

1.83e-04199153M7607
CoexpressionGSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN

CBLB ZC3H4 HNRNPL

1.83e-04199153M3175
CoexpressionGSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN

CXXC5 CREBBP SIPA1L3

1.86e-04200153M9472
CoexpressionGSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP

CXXC5 CREBBP SIPA1L3

1.86e-04200153M9449
CoexpressionGSE6875_WT_VS_FOXP3_KO_TREG_UP

CXXC5 MARCO APBB1IP

1.86e-04200153M6803
CoexpressionGSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN

CXXC5 CREBBP HNRNPL

1.86e-04200153M4667
CoexpressionGSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN

CREBBP APBB1IP AKAP8

1.86e-04200153M8506
CoexpressionGSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN

ZC3H4 CREBBP SIPA1L3

1.86e-04200153M7532
CoexpressionGSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP

CXXC5 CREBBP APBB1IP

1.86e-04200153M3431
CoexpressionAtlasDevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_500

CXXC5 CBLB KANSL1

5.27e-05106153gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k4
ToppCellFetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

IRF4 SIPA1L3 APBB1IP

1.77e-051551539f937ae48767fdcf1a944af4de0530d9c0ab441d
ToppCellFetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

IRF4 SIPA1L3 APBB1IP

2.95e-05184153f4c9272d5cc4a70df051413b5c60ca6d1d80eb84
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CBLB IRF4 KANSL1

3.10e-05187153d17352f769c3c66601b65d060626eecff41b0482
ToppCellControl-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

CXXC5 CBLB APBB1IP

3.30e-0519115333fce8e086601e636e8c6ef2ab58fcfdd52af369
ToppCellFetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

IRF4 SIPA1L3 APBB1IP

3.30e-0519115384452125d1b5b76974e3f9126f611eff16d45c25
ToppCellControl-B_intermediate-14|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

CXXC5 CBLB APBB1IP

3.30e-05191153076302fd247aab6c0b187ac9e0c67a3ba46414ba
ToppCellwk_15-18-Hematologic_Lymphocytic-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

CXXC5 IRF4 APBB1IP

3.35e-0519215347fec69fccbabf9db95e5a1246c67bddf89bc76b
ToppCellNasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

MARCO IRF4 APBB1IP

3.46e-051941533135bc4a8112c5dee108e3b8e775f508b65191f1
ToppCellwk_20-22-Hematologic_Lymphocytic-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CXXC5 IRF4 APBB1IP

3.46e-05194153aca97fbf1a932df457a82709c2a2dc9081e018df
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CBLB IRF4 APBB1IP

3.56e-05196153a65d6a2d9eb3fca8faf323dbc4430e53134b7221
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue

CXXC5 CBLB IRF4

3.56e-051961535755ca4abcae3717894bbf7cbd49bca0a3a03067
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue

CXXC5 CBLB IRF4

3.56e-05196153181f3c1af565355b29f20ca6074147c313ca3477
ToppCell10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

IRF4 APBB1IP HNRNPM

3.62e-05197153106b0f9a0425facc634feb7498c9ba2c55edfbf8
ToppCellwk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

HNRNPH3 HNRNPL HNRNPM

3.73e-05199153d67f5ae05daf942fb79f5b962021f37f4e275f4d
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CXXC5 IRF4 APBB1IP

3.73e-05199153dadee9fc6ce4f4bdb19d29326889316443dda0cb
ToppCellTCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9

SIPA1L3 HNRNPL AKAP8

3.79e-052001530350e5ffd36033099b7e32a1fdd790fff99790dc
ToppCellTCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9

SIPA1L3 HNRNPL AKAP8

3.79e-05200153ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Cbln4_(Neuron.Slc17a7.Cbln4)|Hippocampus / BrainAtlas - Mouse McCarroll V32

DSC3 IRF4

3.15e-0479152397f3a1f5fa67dd0b2ed53ebcad74dedf0498fce
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Cbln4_(Neuron.Slc17a7.Cbln4)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

DSC3 IRF4

3.15e-0479152d24301b6694f64e8bb1b5f0673f653d25d45d3eb
ToppCellcontrol-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CREBBP HNRNPH3

5.87e-04108152e74e73d89d78c8d59dfdd2bd30db54b366a49d23
ToppCellSubstantia_nigra|World / BrainAtlas - Mouse McCarroll V32

FOXA2 MARCO

6.65e-0411515218174b8d57d444fab1e9d2b13d22939c83c958e0
ToppCellLPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IRF4 APBB1IP

7.00e-0411815204355cac58ec046730365d6649aa1e31396901c3
ToppCellNS-control-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CREBBP HNRNPH3

8.10e-041271521f9039d2a9e418c41716c3608d4d03574b71904a
ToppCellcontrol-Myeloid-Monocyte-derived_DC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CREBBP HNRNPH3

8.23e-041281524a1f7b76b64df06531db79e427eda084374ce7b5
ToppCellLPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DSC3 IRF4

8.36e-04129152454bae525f6db3d0dd6347d2a2c3ea9dda9cd212
ToppCellTCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9

FOXA2 IRF4

8.75e-041321526a6718582edfc59c63f2c8f753be81e0f4a7246b
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CBLB IRF4

9.01e-04134152705987fe2abc5ca86abee899755d5ed556ac71ba
ToppCellP03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MARCO APBB1IP

9.97e-041411524a856521520ea73291f4730fe94c5de88c2b6f0c
ToppCellPND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IRF4 APBB1IP

1.10e-031481523f48f5ba0a0928ddf6da7a1be1976933921f42ad
ToppCellP03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MARCO APBB1IP

1.11e-0314915243d756f81d532b5c7f2306e6af9d072d496cbc8e
ToppCellP03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MARCO APBB1IP

1.11e-031491521c5a2572741c47246d455c865e8e1677c9f49598
ToppCellLPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MARCO APBB1IP

1.14e-03151152f13a117ae26ae525da4f3e837d8f204d00dc6ee3
ToppCellLPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DSC3 IRF4

1.16e-031521520c6dd41142e4ca1e54ca41e05e42ed29fbf0e570
ToppCellLPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DSC3 IRF4

1.17e-03153152c81a88d3f707487c511020d3960a1c41e706c6a0
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

CBLB KANSL1

1.22e-031561521545169694f686d28648a68b552c2ae606599d66
ToppCellPND07-28-samps|World / Age Group, Lineage, Cell class and subclass

MARCO APBB1IP

1.23e-03157152a2005768a6d268879e3fd6dbd8cf674dc98be587
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IRF4 SIPA1L3

1.23e-0315715210341ed8cbee0f636770a82cf580f6453bee8596
ToppCelldroplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF4 AKAP8

1.25e-031581521d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCellCOPD-Myeloid-DC_Langerhans|COPD / Disease state, Lineage and Cell class

IRF4 SIPA1L3

1.25e-0315815271af1319eec34bf7bc9361ec9ef720c280ce97d1
ToppCellE16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MARCO APBB1IP

1.26e-031591520c2437da5443fc3aff66f8ef311f02aa434a1fb0
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9

SIPA1L3 AKAP8

1.26e-03159152655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CXXC5 MARCO

1.26e-03159152fb9a45c1d596226128ce4f1adaebb066766e590a
ToppCellCOPD-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class

IRF4 SIPA1L3

1.28e-031601521b73a14ad6546d9f2812c19081278a79260abeae
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DSC3 FOXA2

1.28e-031601526c89a2e4189e4f2b6b09b66c6aae6653785ab2f8
ToppCellLPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DSC3 IRF4

1.28e-03160152dee756a2dc9725520d439e7273c489c2284015d8
ToppCellE18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IRF4 APBB1IP

1.28e-03160152741e3b3f4ec5c77752da54746451f332435226e3
ToppCellPND01-03-samps-Myeloid-Macrophage-macrophage-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass

MARCO APBB1IP

1.30e-031611525925ee646aa040550e3f8a164a13c8a5c0353319
ToppCellChildren_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DSC3 IRF4

1.30e-03161152cd41abb7ae659d3d314281783a0aaad562b26037
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSC3 MARCO

1.30e-03161152b9a63fc9becc44d305fc7c221283bf59ec06b10f
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CXXC5 CBLB

1.31e-031621529b1c07f0af657095379380c39d763cab0ad73e74
ToppCellPND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass

MARCO APBB1IP

1.31e-031621527c73fe8388af370461e04097cf145cbc9847285b
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARCO IRF4

1.31e-03162152b502d6af6868425b5c919740e011330c0d3cf3b8
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MARCO IRF4

1.31e-031621529dca585c734faea0e1122c70f5dc36cef3dbd2c6
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 APBB1IP

1.31e-03162152f12c08d0d4406f9560ecfc3bc2ff38c3bc58f184
ToppCellILEUM-non-inflamed-(3)_pDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CXXC5 IRF4

1.33e-03163152bc5411702badab39143905aa51676b4bbfad2041
ToppCellfacs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CBLB APBB1IP

1.33e-03163152385b24e18df5ef92108483de312d6c85a1e6d145
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CBLB APBB1IP

1.33e-0316315211cc18f36604d9a5f4e7fb8626a8f0fb141da5e1
ToppCellfacs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CBLB APBB1IP

1.33e-031631528004cc0b3428be08b89957b563cd8799f822d931
ToppCellPND01-03-samps-Myeloid-Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass

MARCO APBB1IP

1.34e-0316415249733a9d3d95f05056b5b01916060ff20a8de3cf
ToppCellCOPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class

IRF4 SIPA1L3

1.34e-03164152a07c6e13c07a90bc37db0915eb14931eb8309a1e
ToppCellE18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MARCO APBB1IP

1.36e-031651521dcd6b8aa192baeaa1f7bb334843edab6049b96f
ToppCellNS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

IRF4 APBB1IP

1.36e-031651528b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86
ToppCellcontrol-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

IRF4 APBB1IP

1.36e-03165152243c74adf8d993ff92acbff2768bdc5a1693eca3
ToppCell10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue

CXXC5 CBLB

1.38e-03166152ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCelldroplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF4 APBB1IP

1.38e-03166152e01c720de6d4ca144c55378e023e718a64bf32f6
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CXXC5 CBLB

1.38e-0316615262523e635784512b3261b672beaa7747cb9d114a
ToppCellfacs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARCO IRF4

1.38e-031661526a948aefd283a2572da37b59dbc142b6e686b024
ToppCellfacs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARCO IRF4

1.38e-031661528d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d
ToppCellBronchial_Biopsy-Immune-B_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

IRF4 APBB1IP

1.38e-0316615222e94546b264c87cb55928d1591bf1b5ee2a76bd
ToppCell368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells)

CXXC5 IRF4

1.39e-031671521e2fc1637769405a61f4c7e44945712a1888a299
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CBLB IRF4

1.39e-03167152063ec29b32e40aaa138a691da3a79ee8eef0c2be
ToppCellfacs-Aorta-Heart-24m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZC3H4 IRF4

1.39e-03167152b85fd7ab21c80470bca804c788ce49a2bce763f8
ToppCellILEUM-non-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CXXC5 IRF4

1.39e-031671528ddf9da71a7c4ed53588435db826563a24cee616
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CXXC5 IRF4

1.39e-031671523c3e1c31aacca48099693aea2efdfa22fc0e4af4
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CXXC5 IRF4

1.39e-0316715277a4d7ce44847c76074d4f5340d61b398fe43e6c
ToppCelldroplet-Pancreas-PANCREAS-30m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF4 APBB1IP

1.41e-031681525946204d42307391bc2160abe12850815f350aea
ToppCellPND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MARCO APBB1IP

1.41e-03168152a1755afa2cc50960ba60e07d84d61be429cdea72
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DSC3 IRF4

1.41e-031681524b2d29a7843bf45922038c093ca7ec0600756adc
ToppCellPND07-28-samps-Myeloid|PND07-28-samps / Age Group, Lineage, Cell class and subclass

MARCO APBB1IP

1.41e-0316815287512f9e5e95333e7ffc6efa1e93bab2ba9154c6
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CXXC5 CBLB

1.41e-03168152b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DSC3 FOXA2

1.41e-0316815217d46f993dc4ae22b8087808582aba77f5c61892
ToppCell5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CBLB APBB1IP

1.43e-031691528caf7996796a2e2716e3855de855c903d6126bf2
ToppCellBronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

IRF4 APBB1IP

1.43e-03169152dc388f660f69e37e517bf3243daf071ab138ee6e
ToppCellfacs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARCO APBB1IP

1.43e-031691520f5e737b265ba333275a0cd289dab029a1542075
ToppCellwk_08-11-Hematologic_Lymphocytic-B-Late_pro-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

IRF4 APBB1IP

1.44e-03170152ad69ebfda452e19eedc453e1d07dacb844d64e47
ToppCelldroplet-Liver-Npc|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARCO APBB1IP

1.44e-0317015209c836840216905d545a25a4fc1bbd0699576c77
ToppCellCOVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

MARCO APBB1IP

1.44e-031701524232fe937909f93d3736988c707b8f95ce993398
ToppCellCOVID-19_Moderate-NK_CD56bright|World / disease group, cell group and cell class

CXXC5 CBLB

1.44e-03170152caa6a534c1e9639caced9a51680f5c905f061bcc
ToppCelltumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass

IRF4 APBB1IP

1.46e-03171152dcb6c41980008d0b9eeb54999faff77311554976
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 APBB1IP

1.46e-03171152a350a5f840e0fb0ccd29bb29cacc23a89abd8404
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DSC3 IRF4

1.46e-031711525d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CXXC5 IRF4

1.46e-03171152714a0b0d0c9886fef64170cf53eb64f0d8a47280
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 APBB1IP

1.46e-03171152e0a99ca8d4c86b58f54af7755ffd8e0ffbfae5e1
ToppCell3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 APBB1IP

1.46e-0317115258bdcbc65062ac09f1c014e08302f938a3e6b252
ToppCellLPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IRF4 APBB1IP

1.46e-03171152539ea88acc6f948efdeae8b69e5c5ffaee29f1d9
ToppCellHealthy/Control-NK_CD56bright|World / Disease group and Cell class

CXXC5 CBLB

1.46e-0317115279d7efefdae267905af05f3001514b8b6934d86e
ToppCelldroplet-Liver-Npc-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARCO APBB1IP

1.46e-03171152e9c42ce444d42cbb4f97e81393756531bfe61637
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CXXC5 SIPA1L3

1.46e-03171152b6ee3a6bc436df5e9129b8e0bed9fa3078a4ff23
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

CBLB KANSL1

1.46e-031711522e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IRF4 APBB1IP

1.46e-03171152af1c93eb75f45c042ea475d93db56e4da207e31f
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 CREBBP AKAP8

3.84e-061701543791_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 CREBBP AKAP8

4.02e-061721546439_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 CREBBP AKAP8

4.31e-061751546316_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 CREBBP AKAP8

4.41e-061761546546_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 CREBBP AKAP8

4.51e-061771546340_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP HNRNPH3 AKAP8

4.71e-061791542105_DN
DrugAC1L1AUZ

HNRNPH3 HNRNPL HNRNPM

1.38e-04157153CID000001160
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.54e-041631537453_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FOXA2 CREBBP AKAP8

1.54e-041631537285_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

ZC3H4 CREBBP AKAP8

1.74e-041701531050_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.74e-041701533746_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.77e-041711536879_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.77e-041711531234_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.80e-041721533428_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

ZC3H4 CREBBP AKAP8

1.80e-041721531072_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.80e-041721532794_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.80e-041721537073_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.83e-041731535987_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.83e-041731534565_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.83e-041731533243_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.83e-041731534458_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.87e-041741533993_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.87e-041741531659_DN
DrugAC1NRA5C

HNRNPH3 HNRNPL HNRNPM

1.87e-04174153CID005287709
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA

ZC3H4 CREBBP AKAP8

1.90e-041751531058_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.90e-041751533787_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.90e-041751537236_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

ZC3H4 CREBBP AKAP8

1.90e-041751531014_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.93e-041761534632_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.93e-041761531535_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.93e-041761533312_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.93e-041761537499_DN
Drugtrichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA

ZC3H4 CREBBP AKAP8

1.93e-04176153981_DN
Drugtrichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA

ZC3H4 CREBBP AKAP8

1.96e-04177153873_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.96e-041771531645_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.96e-041771533227_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.96e-041771536434_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.96e-041771537047_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.99e-041781534436_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 CREBBP

1.99e-041781537245_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

ZC3H4 CREBBP AKAP8

1.99e-041781531112_DN
DrugSAHA; Down 200; 10uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

1.99e-041781534444_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

2.03e-041791536609_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

2.06e-041801533688_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

CBLB ZC3H4 CREBBP

2.06e-041801534541_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

2.06e-041801531793_DN
DrugSAHA; Down 200; 10uM; HL60; HT_HG-U133A

ZC3H4 APBB1IP AKAP8

2.06e-041801532680_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

ZC3H4 CREBBP AKAP8

2.10e-041811537077_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZC3H4 CREBBP AKAP8

2.10e-041811537005_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

ZC3H4 CREBBP AKAP8

2.13e-041821531891_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

ZC3H4 CREBBP AKAP8

2.13e-041821531951_DN
Drugscriptaid; Down 200; 10uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 CREBBP

2.13e-041821536896_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FOXA2 ZC3H4 AKAP8

2.20e-041841537555_DN
DrugPiperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A

DSC3 IRF4 SIPA1L3

2.69e-041971533939_DN
DrugIndapamide [26807-65-8]; Up 200; 10.6uM; HL60; HT_HG-U133A

DSC3 SIPA1L3 APBB1IP

2.69e-041971532361_UP
Drug(d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; HL60; HT_HG-U133A

DSC3 IRF4 SIPA1L3

2.69e-041971532163_UP
DrugAzlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; HL60; HT_HG-U133A

DSC3 IRF4 SIPA1L3

2.73e-041981532727_UP
DrugC75; Up 200; 10uM; MCF7; HT_HG-U133A

DSC3 CREBBP IRF4

2.77e-041991536394_UP
Drugnordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A

DSC3 SIPA1L3 APBB1IP

2.77e-041991532683_DN
DrugCefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; PC3; HT_HG-U133A

CREBBP IRF4 APBB1IP

2.77e-041991534067_UP
DrugPipenzolate bromide [125-51-9]; Up 200; 9.2uM; HL60; HT_HG-U133A

MARCO IRF4 APBB1IP

2.81e-042001532719_UP
DrugSulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A

DSC3 IRF4 SIPA1L3

2.81e-042001534769_UP
DrugNitrofural [59-87-0]; Up 200; 20.2uM; HL60; HT_HG-U133A

DSC3 IRF4 APBB1IP

2.81e-042001532459_UP
Diseaseneutrophil percentage of granulocytes

IRF4 APBB1IP KANSL1

1.56e-04228143EFO_0007994
Diseaseeosinophil percentage of granulocytes

IRF4 APBB1IP KANSL1

1.68e-04234143EFO_0007996
Diseasebasophil count, eosinophil count

IRF4 APBB1IP KANSL1

1.83e-04241143EFO_0004842, EFO_0005090
Diseaseacute lymphoblastic leukemia (is_implicated_in)

CREBBP IRF4

3.06e-0455142DOID:9952 (is_implicated_in)
Diseaseeosinophil count

CBLB IRF4 SIPA1L3 APBB1IP KANSL1

4.42e-041488145EFO_0004842
Diseaseglucose measurement

FOXA2 ZC3H4 APBB1IP

6.94e-04380143EFO_0004468
Diseaseage of onset of childhood onset asthma

IRF4 KANSL1

8.54e-0492142OBA_2001015
DiseaseAdenoid Cystic Carcinoma

CREBBP KANSL1

1.01e-03100142C0010606
Diseasepuberty onset measurement

IRF4 KANSL1

1.57e-03125142EFO_0005677
Diseaseautoimmune thyroid disease

CBLB IRF4

1.59e-03126142EFO_0006812
Diseaseandrogenetic alopecia

IRF4 KANSL1

1.77e-03133142EFO_0004191
Diseaseskin pigmentation measurement

MARCO IRF4

1.88e-03137142EFO_0007009
DiseaseLeukemia, Myelocytic, Acute

CBLB CREBBP

2.97e-03173142C0023467
Diseaseautoimmune disease

CBLB IRF4

2.97e-03173142EFO_0005140
Diseaseskin aging measurement

MARCO IRF4

3.24e-03181142EFO_0008006
Diseaselymphocyte percentage of leukocytes

IRF4 APBB1IP KANSL1

3.45e-03665143EFO_0007993
Diseasebody fat distribution

CXXC5 ZC3H4

4.02e-03202142EFO_0004341
Diseasemonocyte percentage of leukocytes

IRF4 APBB1IP KANSL1

4.49e-03731143EFO_0007989
DiseaseThyroid preparation use measurement

CBLB IRF4

4.62e-03217142EFO_0009933
Diseaseeosinophil percentage of leukocytes

IRF4 APBB1IP KANSL1

4.76e-03746143EFO_0007991

Protein segments in the cluster

PeptideGeneStartEntry
DMMSKEGGRGGSGGG

AKAP8

101

O43823
GGAGGGEQDFMSDLM

APBB1IP

641

Q7Z5R6
QGSAGMAGGMAGHGQ

CREBBP

2216

Q92793
MNLEGGGRGGEFGMS

IRF4

1

Q15306
RMGLAMGGGGGASFD

HNRNPM

606

P52272
MANSMNGRNPGGRGG

CBLB

1

Q13191
GEMGGSESGDLKGGM

KANSL1

191

Q7Z3B3
GMGGYGRDGMDNQGG

HNRNPH3

281

P31942
SGGGSMMGGESADKA

CXXC5

91

Q7LFL8
QGFCGTMGSGMKNGG

DSC3

761

Q14574
GSKGDRGMKGDAGVM

MARCO

256

Q9UEW3
AMVKMAAAGGGGGGG

HNRNPL

31

P14866
AMAGMGGSAGAAGVA

FOXA2

86

Q9Y261
MGGGGGAKGDSHNGQ

SIPA1L3

251

O60292
GGSRGGMNKGGMNDD

ZC3H4

346

Q9UPT8